Whereas most carcinomas occur through a sequential step, atypical adenomatous hyperplasia and bronchioloalveolar carcinoma pathway is known for pulmonary adenocarcinoma. This type is known as terminal respiratory unit adenocarcinoma. Based on our observation of transitions from normal ciliated columnar cells to adenocarcinoma via dysplastic mucous columnar cells, we reviewed our archive of pulmonary adenocarcinoma. Terminal respiratory unit type adenocarcinoma was defined as adenocarcinoma with type II pneumocyte, Clara cell, or bronchiolar cell morphology according to previous reports. Among 157 cases, 121 cases have been identified as terminal respiratory unit type adenocarcinoma and 36 cases as non-terminal respiratory unit type adenocarcinoma. Among non-terminal respiratory unit type adenocarcinoma, 24 cases revealed mucous columnar cell changes that were continuous with bronchial ciliated columnar cells. The mucous columnar cells became dysplastic showing loss of cilia, disorientation, and enlarged nuclei. Adenocarcinoma arose from these dysplastic mucous columnar cells and, characteristically, this type of adenocarcinoma showed acute inflammation, and honeycombing changes in the background. TTF1 immunostaining was consistently negative. In a case study with 14 males and 10 females, including 12 smokers or ex-smokers, EGFR and KRAS mutations were detected in 3 and 6 patients, respectively. We think that this kind of adenocarcinoma arising through mucous columnar cell change belongs to non-terminal respiratory unit type adenocarcinoma, and mucous columnar cell change is a precursor lesion of pulmonary adenocarcinoma. Keywords: adenocarcinoma; lung; mucous columnar cell change Most carcinomas, including squamous cell carcinoma in the head and neck, uterine cervix, and skin, and adenocarcinomas in sites including the gastrointestinal tract, biliary tract, breast, and prostate occur through a sequence of steps from normal epithelium to hyperplasia, dysplasia, carcinoma in situ, and invasive carcinoma. 1 In the lung, squamous carcinoma arises by a similar pathway, beginning from squamous metaplasia in bronchus or bronchiole that is caused by various irritants. 2 Adenocarcinoma is considered to develop by a pathway of atypical adenomatous hyperplasia and bronchioloalveolar carcinoma. 2-4 However, whether atypical adenomatous hyperplasia-bronchioloalveolar carcinoma pathway is really the only pathway for pulmonary adenocarcinoma has been questioned on the basis of a number of observations. 5 First, atypical adenomatous hyperplasias are not as common as adenocarcinomas with features of bronchioloalveolar carcinoma or premalignant lesions in other organs. 3,5 Second, atypical adenomatous hyperplasia is morphologically different from pre-adenocarcinoma lesions in other organs such as adenoma, prostatic intraepithelial neoplasia, or biliary intraepithelial neoplasia showing nuclear stratification, elongation, and overlap. Third, peripheral pulmonary parenchyma in which atypical adenomatous hyperplasia or bronchioloalv...